A detailed history of Cowen Prime Advisors LLC transactions in Pharming Group N.V. stock. As of the latest transaction made, Cowen Prime Advisors LLC holds 22,460 shares of PHAR stock, worth $169,123. This represents 0.09% of its overall portfolio holdings.

Number of Shares
22,460
Previous 22,460 -0.0%
Holding current value
$169,123
Previous $250,000 4.4%
% of portfolio
0.09%
Previous 0.1%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

BUY
$10.24 - $14.96 $8,704 - $12,716
850 Added 3.93%
22,460 $250,000
Q4 2022

Feb 01, 2023

BUY
$9.17 - $13.5 $45,024 - $66,285
4,910 Added 29.4%
21,610 $238,000
Q3 2022

Nov 07, 2022

BUY
$6.85 - $12.62 $1,370 - $2,524
200 Added 1.21%
16,700 $164,000
Q2 2022

Aug 01, 2022

BUY
$6.61 - $9.64 $4,296 - $6,266
650 Added 4.1%
16,500 $145,000
Q1 2022

May 02, 2022

BUY
$7.75 - $10.05 $8,137 - $10,552
1,050 Added 7.09%
15,850 $142,000
Q4 2021

Feb 08, 2022

BUY
$7.58 - $10.1 $64,430 - $85,850
8,500 Added 134.92%
14,800 $132,000
Q2 2021

Aug 04, 2021

SELL
$10.95 - $13.58 $111,690 - $138,516
-10,200 Reduced 61.82%
6,300 $71,000
Q2 2020

Aug 01, 2022

BUY
N/A
16,500 New
16,500 $145,000

Others Institutions Holding PHAR

About Pharming Group N.V.


  • Ticker PHAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,241,400
  • Market Cap $491M
  • Description
  • Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the tre...
More about PHAR
Track This Portfolio

Track Cowen Prime Advisors LLC Portfolio

Follow Cowen Prime Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen Prime Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen Prime Advisors LLC with notifications on news.